Cargando…

PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer

BACKGROUND AND OBJECTIVES: The occurrence and development of lung cancer are closely linked to epigenetic modification. Abnormal DNA methylation in the CpG island region of genes has been found in many cancers. Protein kinase C delta binding protein (PRKCDBP) is a potential tumor suppressor and its...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, Jing, QI, Lin, ZHANG, Mingfang, YAO, Caiyun, FENG, Jinan, ZHENG, Zhonghua, CHEN, Chujia, DUAN, Shiwei, QI, Yuanlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	中国肺癌杂志编辑部 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913286/ https://www.ncbi.nlm.nih.gov/pubmed/35224960 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.03

Ejemplares similares

Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer
por: Qi, Yuanlin, et al.
Publicado: (2020)

Low expression of PRKCDBP promoted cisplatin resistance in lung adenocarcinoma by DNMT1 and TNF-α
por: Fu, Jiali, et al.
Publicado: (2020)

Cavin-3 (PRKCDBP) deficiency reduces the density of caveolae in smooth muscle
por: Zhu, Baoyi, et al.
Publicado: (2017)

Polymorphisms in PRKCDBP, a Transcriptional Target of TNF-α, Are Associated With Inflammatory Bowel Disease in Korean
por: Kim, Jung-Wook, et al.
Publicado: (2015)

Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data
por: Li, Chengrui, et al.
Publicado: (2021)

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

Albumin‐to‐fibrinogen ratio as a promising biomarker to predict clinical outcome of non‐small cell lung cancer individuals
por: Li, Shu‐Qi, et al.
Publicado: (2018)

Ruthenium Complexes as Promising Candidates against Lung Cancer
por: Sun, Qi, et al.
Publicado: (2021)

The sodium new houttuyfonate suppresses NSCLC via activating pyroptosis through TCONS‐14036/miR‐1228‐5p/PRKCDBP pathway
por: Jiang, Rilei, et al.
Publicado: (2023)

Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma
por: Li, Jingyuan, et al.
Publicado: (2020)

Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer
por: Ibrahim, Joe, et al.
Publicado: (2019)

CSF1R and HCST: Novel Candidate Biomarkers Predicting the Response to Immunotherapy in Non-Small Cell Lung Cancer
por: Qi, Xiaoguang, et al.
Publicado: (2020)

Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non–small-cell lung carcinoma
por: Luo, Ruihan, et al.
Publicado: (2020)

miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer
por: Xu, Yuejuan, et al.
Publicado: (2012)

Neopterin: A Promising Candidate Biomarker for Severe COVID-19
por: Hailemichael, Wasihun, et al.
Publicado: (2021)

Circular RNAs in extracellular vesicles: Promising candidate biomarkers for schizophrenia
por: Guo, Chuang, et al.
Publicado: (2023)

Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis
por: Wu, Qiong, et al.
Publicado: (2019)

Genome-Wide Prediction of DNA Methylation Using DNA Composition and Sequence Complexity in Human
por: Wu, Chengchao, et al.
Publicado: (2017)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
por: Rao, Qian‐Wen, et al.
Publicado: (2020)

GPX3 methylation is associated with hematologic improvement in low-risk myelodysplastic syndrome patients treated with Pai-Neng-Da
por: Yang, Shujun, et al.
Publicado: (2020)

Plasma miR-124 Is a Promising Candidate Biomarker for Human Intracerebral Hemorrhage Stroke
por: Wang, Zifeng, et al.
Publicado: (2017)

Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer
por: Liu, Shunlin, et al.
Publicado: (2017)

PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study
por: Takahashi, Hirokazu, et al.
Publicado: (2010)

Quinolines derivatives as promising new antifungal candidates for the treatment of candidiasis and dermatophytosis
por: da Rosa Monte Machado, Gabriella, et al.
Publicado: (2020)

Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
por: Sun, Zhi-Kun, et al.
Publicado: (2013)

Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis
por: Elfimova, Natalia, et al.
Publicado: (2012)

Targeting glycolysis in non-small cell lung cancer: Promises and challenges
por: Xu, Jia-Qi, et al.
Publicado: (2022)

Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma
por: Chen, Xiongfeng, et al.
Publicado: (2022)

Old drug repurposing for neglected disease: Pyronaridine as a promising candidate for the treatment of Echinococcus granulosus infections
por: Li, Jun, et al.
Publicado: (2020)

Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients
por: Huang, Tao, et al.
Publicado: (2015)

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis
por: Yu, Liyan, et al.
Publicado: (2023)

Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
por: Huang, Lanxiang, et al.
Publicado: (2021)

Metabolic characteristics of large and small extracellular vesicles from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy
por: Luo, Ping, et al.
Publicado: (2020)

Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer
por: BODDU, Prajwal, et al.
Publicado: (2016)

Leucocyte-derived micro-RNAs as candidate biomarkers in Brugada syndrome
por: Steinberg, Christian, et al.
Publicado: (2023)

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis
por: Ni, Mengwei, et al.
Publicado: (2018)

APC and AXIN2 Are Promising Biomarker Candidates for the Early Detection of Adenomas and Hyperplastic Polyps
por: Rezasoltani, Sama, et al.
Publicado: (2020)

The Angiopoietin-like protein 4: a promising biomarker to distinguish brucella spondylitis from tuberculous spondylitis
por: Lan, Siqin, et al.
Publicado: (2021)

Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma
por: Ağababaoğlu, İsmail, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c15m3oc1s4op7a7nvpn3eicdaa